Report Detail
Global Drugs for Melanoma Market Professional Survey Report 2019
- RnM3800795 |
- 03 October, 2019 |
- Global |
- 104 Pages |
- QYResearch |
- Pharma & Healthcare
Melanoma is the type of cancer, in which the normal melanin-producing cells called melanocytes are turned into cancerous cells. Melanoma is usually, but not always cancer of the skin and is the most dangerous type of cancer. Mutation in melanin-producing melanocytes leads to uncontrolled division of cells forming the malignant tumor. Mainly there are three general categories of melanoma as Cutaneous, mucosal and ocular. Cutaneous melanoma is melanoma of the skin and is most common because most pigment cells are found in the skin. Mucosal melanoma is melanoma of mucous membrane of the body, including the mouth, the nasal passages, the throat, the vagina or the anus. The rare ocular melanoma or uveal melanoma occurs in the eye.
The global Drugs for Melanoma market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Drugs for Melanoma volume and value at global level, regional level and company level. From a global perspective, this report represents overall Drugs for Melanoma market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Drugs for Melanoma in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Drugs for Melanoma manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Amgen
Bristol-Myers Squibb
Roche
Genentech
Janssen Biotech
Novartis
Pfizer
Sanofi
Takeda Pharma
Teva Pharma
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
Chemotherapy
Immunotherapy
Targeted Therapy
Segment by Application
Hospitals
Clinics
Others
Table of Contents
Executive Summary
1 Industry Overview of Drugs for Melanoma
- 1.1 Definition of Drugs for Melanoma
- 1.2 Drugs for Melanoma Segment by Type
- 1.2.1 Global Drugs for Melanoma Production Growth Rate Comparison by Types (2014-2025)
- 1.2.2 Chemotherapy
- 1.2.3 Immunotherapy
- 1.2.4 Targeted Therapy
- 1.3 Drugs for Melanoma Segment by Applications
- 1.3.1 Global Drugs for Melanoma Consumption Comparison by Applications (2014-2025)
- 1.3.2 Hospitals
- 1.3.3 Clinics
- 1.3.4 Others
- 1.4 Global Drugs for Melanoma Overall Market
- 1.4.1 Global Drugs for Melanoma Revenue (2014-2025)
- 1.4.2 Global Drugs for Melanoma Production (2014-2025)
- 1.4.3 North America Drugs for Melanoma Status and Prospect (2014-2025)
- 1.4.4 Europe Drugs for Melanoma Status and Prospect (2014-2025)
- 1.4.5 China Drugs for Melanoma Status and Prospect (2014-2025)
- 1.4.6 Japan Drugs for Melanoma Status and Prospect (2014-2025)
- 1.4.7 Southeast Asia Drugs for Melanoma Status and Prospect (2014-2025)
- 1.4.8 India Drugs for Melanoma Status and Prospect (2014-2025)
2 Manufacturing Cost Structure Analysis
- 2.1 Raw Material and Suppliers
- 2.2 Manufacturing Cost Structure Analysis of Drugs for Melanoma
- 2.3 Manufacturing Process Analysis of Drugs for Melanoma
- 2.4 Industry Chain Structure of Drugs for Melanoma
3 Development and Manufacturing Plants Analysis of Drugs for Melanoma
- 3.1 Capacity and Commercial Production Date
- 3.2 Global Drugs for Melanoma Manufacturing Plants Distribution
- 3.3 Major Manufacturers Technology Source and Market Position of Drugs for Melanoma
- 3.4 Recent Development and Expansion Plans
4 Key Figures of Major Manufacturers
- 4.1 Drugs for Melanoma Production and Capacity Analysis
- 4.2 Drugs for Melanoma Revenue Analysis
- 4.3 Drugs for Melanoma Price Analysis
- 4.4 Market Concentration Degree
5 Drugs for Melanoma Regional Market Analysis
- 5.1 Drugs for Melanoma Production by Regions
- 5.1.1 Global Drugs for Melanoma Production by Regions
- 5.1.2 Global Drugs for Melanoma Revenue by Regions
- 5.2 Drugs for Melanoma Consumption by Regions
- 5.3 North America Drugs for Melanoma Market Analysis
- 5.3.1 North America Drugs for Melanoma Production
- 5.3.2 North America Drugs for Melanoma Revenue
- 5.3.3 Key Manufacturers in North America
- 5.3.4 North America Drugs for Melanoma Import and Export
- 5.4 Europe Drugs for Melanoma Market Analysis
- 5.4.1 Europe Drugs for Melanoma Production
- 5.4.2 Europe Drugs for Melanoma Revenue
- 5.4.3 Key Manufacturers in Europe
- 5.4.4 Europe Drugs for Melanoma Import and Export
- 5.5 China Drugs for Melanoma Market Analysis
- 5.5.1 China Drugs for Melanoma Production
- 5.5.2 China Drugs for Melanoma Revenue
- 5.5.3 Key Manufacturers in China
- 5.5.4 China Drugs for Melanoma Import and Export
- 5.6 Japan Drugs for Melanoma Market Analysis
- 5.6.1 Japan Drugs for Melanoma Production
- 5.6.2 Japan Drugs for Melanoma Revenue
- 5.6.3 Key Manufacturers in Japan
- 5.6.4 Japan Drugs for Melanoma Import and Export
- 5.7 Southeast Asia Drugs for Melanoma Market Analysis
- 5.7.1 Southeast Asia Drugs for Melanoma Production
- 5.7.2 Southeast Asia Drugs for Melanoma Revenue
- 5.7.3 Key Manufacturers in Southeast Asia
- 5.7.4 Southeast Asia Drugs for Melanoma Import and Export
- 5.8 India Drugs for Melanoma Market Analysis
- 5.8.1 India Drugs for Melanoma Production
- 5.8.2 India Drugs for Melanoma Revenue
- 5.8.3 Key Manufacturers in India
- 5.8.4 India Drugs for Melanoma Import and Export
6 Drugs for Melanoma Segment Market Analysis (by Type)
- 6.1 Global Drugs for Melanoma Production by Type
- 6.2 Global Drugs for Melanoma Revenue by Type
- 6.3 Drugs for Melanoma Price by Type
7 Drugs for Melanoma Segment Market Analysis (by Application)
- 7.1 Global Drugs for Melanoma Consumption by Application
- 7.2 Global Drugs for Melanoma Consumption Market Share by Application (2014-2019)
8 Drugs for Melanoma Major Manufacturers Analysis
- 8.1 Amgen
- 8.1.1 Amgen Drugs for Melanoma Production Sites and Area Served
- 8.1.2 Amgen Product Introduction, Application and Specification
- 8.1.3 Amgen Drugs for Melanoma Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.1.4 Main Business and Markets Served
- 8.2 Bristol-Myers Squibb
- 8.2.1 Bristol-Myers Squibb Drugs for Melanoma Production Sites and Area Served
- 8.2.2 Bristol-Myers Squibb Product Introduction, Application and Specification
- 8.2.3 Bristol-Myers Squibb Drugs for Melanoma Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.2.4 Main Business and Markets Served
- 8.3 Roche
- 8.3.1 Roche Drugs for Melanoma Production Sites and Area Served
- 8.3.2 Roche Product Introduction, Application and Specification
- 8.3.3 Roche Drugs for Melanoma Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.3.4 Main Business and Markets Served
- 8.4 Genentech
- 8.4.1 Genentech Drugs for Melanoma Production Sites and Area Served
- 8.4.2 Genentech Product Introduction, Application and Specification
- 8.4.3 Genentech Drugs for Melanoma Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.4.4 Main Business and Markets Served
- 8.5 Janssen Biotech
- 8.5.1 Janssen Biotech Drugs for Melanoma Production Sites and Area Served
- 8.5.2 Janssen Biotech Product Introduction, Application and Specification
- 8.5.3 Janssen Biotech Drugs for Melanoma Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.5.4 Main Business and Markets Served
- 8.6 Novartis
- 8.6.1 Novartis Drugs for Melanoma Production Sites and Area Served
- 8.6.2 Novartis Product Introduction, Application and Specification
- 8.6.3 Novartis Drugs for Melanoma Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.6.4 Main Business and Markets Served
- 8.7 Pfizer
- 8.7.1 Pfizer Drugs for Melanoma Production Sites and Area Served
- 8.7.2 Pfizer Product Introduction, Application and Specification
- 8.7.3 Pfizer Drugs for Melanoma Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.7.4 Main Business and Markets Served
- 8.8 Sanofi
- 8.8.1 Sanofi Drugs for Melanoma Production Sites and Area Served
- 8.8.2 Sanofi Product Introduction, Application and Specification
- 8.8.3 Sanofi Drugs for Melanoma Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.8.4 Main Business and Markets Served
- 8.9 Takeda Pharma
- 8.9.1 Takeda Pharma Drugs for Melanoma Production Sites and Area Served
- 8.9.2 Takeda Pharma Product Introduction, Application and Specification
- 8.9.3 Takeda Pharma Drugs for Melanoma Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.9.4 Main Business and Markets Served
- 8.10 Teva Pharma
- 8.10.1 Teva Pharma Drugs for Melanoma Production Sites and Area Served
- 8.10.2 Teva Pharma Product Introduction, Application and Specification
- 8.10.3 Teva Pharma Drugs for Melanoma Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.10.4 Main Business and Markets Served
9 Development Trend of Analysis of Drugs for Melanoma Market
- 9.1 Global Drugs for Melanoma Market Trend Analysis
- 9.1.1 Global Drugs for Melanoma Market Size (Volume and Value) Forecast 2019-2025
- 9.2 Drugs for Melanoma Regional Market Trend
- 9.2.1 North America Drugs for Melanoma Forecast 2019-2025
- 9.2.2 Europe Drugs for Melanoma Forecast 2019-2025
- 9.2.3 China Drugs for Melanoma Forecast 2019-2025
- 9.2.4 Japan Drugs for Melanoma Forecast 2019-2025
- 9.2.5 Southeast Asia Drugs for Melanoma Forecast 2019-2025
- 9.2.6 India Drugs for Melanoma Forecast 2019-2025
- 9.3 Drugs for Melanoma Market Trend (Product Type)
- 9.4 Drugs for Melanoma Market Trend (Application)
- 10.1 Marketing Channel
- 10.1.1 Direct Marketing
- 10.1.2 Indirect Marketing
- 10.3 Drugs for Melanoma Customers
11 Market Dynamics
- 11.1 Market Trends
- 11.2 Opportunities
- 11.3 Market Drivers
- 11.4 Challenges
- 11.5 Influence Factors
12 Conclusion
13 Appendix
- 13.1 Methodology/Research Approach
- 13.1.1 Research Programs/Design
- 13.1.2 Market Size Estimation
- 13.1.3 Market Breakdown and Data Triangulation
- 13.2 Data Source
- 13.2.1 Secondary Sources
- 13.2.2 Primary Sources
- 13.3 Author List
Summary:
Get latest Market Research Reports on Drugs for Melanoma. Industry analysis & Market Report on Drugs for Melanoma is a syndicated market report, published as Global Drugs for Melanoma Market Professional Survey Report 2019. It is complete Research Study and Industry Analysis of Drugs for Melanoma market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
